SIRT5 and Alzheimer disease: Cd, an environmental factor, is one of the potential risks associated with the development of AD.[7] FAD4T mice, which serve as a reliable AD model and express accelerated amyloid plaques (1.5 months) accompanied by memory deficits (5 months),[43] were used to evaluate the potential therapeutic efficacy of SIRT5 in this study.